Impact of embryo quality and endometrial thickness on implantation in natural cycle IVF.


Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
05 2020
Historique:
received: 01 10 2019
accepted: 12 03 2020
pubmed: 27 3 2020
medline: 1 9 2020
entrez: 27 3 2020
Statut: ppublish

Résumé

The aim of this study is to assess the effect of the endometrial thickness and embryo quality on the implantation potential in natural cycle IVF (NC-IVF). A retrospective single-center study was performed on 552 single embryo transfers after NC-IVF. The 'quality' of the embryos was evaluated trough the number and regularity of blastomeres, degree of fragmentation, and nuclear content of cells. Endometrial thickness was measured in millimeters with transvaginal ultrasound on the day of hCG application. Our findings showed a statistically significant difference in successful implantation until a plateau of 10 mm is reached (p = 0.001). Only one pregnancy was achieved where endometrial thickness was less than 7 mm, and this resulted in an early miscarriage. The predictors of favorable implantation were fragmentation (≤ 10%, p < 0.05) and the number of blastomeres (preferably 8-cell, p < 0.01) on day 3. Embryo quality (R = 0.052) and endometrial thickness (R = 0.18) were closely related to pregnancy rate. The overall implantation rate per embryo transfer was 18.8%. Embryo quality and endometrial thickness have a significant impact on implantation in NC-IVF. Highest implantation potential has an 8-cell embryo with ≤ 10% fragmentation in the third day following oocyte retrieval. Endometrial thickness of at least 7 mm seems to be the optimal edge of successful pregnancy.

Identifiants

pubmed: 32211954
doi: 10.1007/s00404-020-05507-4
pii: 10.1007/s00404-020-05507-4
pmc: PMC7181434
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1325-1330

Références

Hum Reprod. 2017 Apr 1;32(4):820-831
pubmed: 28201504
Hum Reprod. 2001 Feb;16(2):326-32
pubmed: 11157828
Fertil Steril. 2009 Oct;92(4):1297-301
pubmed: 18793777
Hum Reprod. 2007 Feb;22(2):548-57
pubmed: 17095516
Acta Obstet Gynecol Scand. 2018 Mar;97(3):269-276
pubmed: 29247514
Int J Gynaecol Obstet. 2003 Jun;81(3):287-92
pubmed: 12767571
Afr J Reprod Health. 2009 Mar;13(1):113-21
pubmed: 20687269
Hum Reprod. 2004 Jun;19(6):1457-60
pubmed: 15105402
Fertil Steril. 2008 Apr;89(4):832-9
pubmed: 17681313
Reprod Biol Endocrinol. 2009 Apr 22;7:33
pubmed: 19386129
Fertil Steril. 2007 Jan;87(1):53-9
pubmed: 17081537
Ann N Y Acad Sci. 2004 Dec;1034:245-51
pubmed: 15731316
Best Pract Res Clin Endocrinol Metab. 2019 Feb;33(1):77-88
pubmed: 31005505
PLoS One. 2015 Dec 30;10(12):e0145703
pubmed: 26717148
Reprod Biomed Online. 2014 Sep;29(3):291-8
pubmed: 25070912
Fertil Steril. 2010 Jul;94(2):527-34
pubmed: 19439287
Reprod Biol Endocrinol. 2008 Sep 02;6:37
pubmed: 18764940
Hum Reprod. 2018 Oct 1;33(10):1883-1888
pubmed: 30239738
Hum Reprod Update. 2014 Jul-Aug;20(4):530-41
pubmed: 24664156
Best Pract Res Clin Endocrinol Metab. 2019 Feb;33(1):35-45
pubmed: 30473207
Reprod Biomed Online. 2013 Nov;27(5):530-8
pubmed: 23933035
Fertil Steril. 2013 Apr;99(5):1299-1304.e3
pubmed: 23540611
J Reprod Med. 2014 Nov-Dec;59(11-12):553-9
pubmed: 25552127
Eur J Obstet Gynecol Reprod Biol. 2005 Jun 1;120(2):179-84
pubmed: 15925048
J Assist Reprod Genet. 2018 May;35(5):809-816
pubmed: 29502189
Gynecol Obstet Invest. 2007;64(3):131-3
pubmed: 17934307
Front Endocrinol (Lausanne). 2018 Dec 20;9:776
pubmed: 30619099
Curr Opin Obstet Gynecol. 2013 Aug;25(4):274-9
pubmed: 23787799
Reprod Biol Endocrinol. 2019 Jun 24;17(1):49
pubmed: 31234873

Auteurs

Vlatka Tomic (V)

Department of Obstetrics and Gynecology, Paracelsus Medical University, Müllner Hauptstrasse 48, 5020, Salzburg, Austria. tomic.vlatka@gmail.com.

Miro Kasum (M)

Department of Obstetrics and Gynecology, School of Medicine, University Hospital Centre Zagreb, University of Zagreb, Zagreb, Croatia.

Katarina Vucic (K)

European Medicines Agency, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH